Plato Investment Management’s Gilead Sciences GILD Stock Holding History

Plato Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.15M	Buy	51,281 +2,426	+5%	+$340K	0.48%	42
2025 Q4	$6.03M	Sell	48,855 -2,227	-4%	-$271K	0.39%	54
2025 Q3	$5.63M	Buy	51,082 +6,668	+15%	+$758K	0.38%	54
2025 Q2	$4.91M	Sell	44,414 -2,068	-4%	-$220K	0.37%	60
2025 Q1	$5.26M	Sell	46,482 -15,097	-25%	-$1.56M	0.44%	42
2024 Q4	$5.71M	Buy	61,579 +10,758	+21%	+$969K	0.42%	48
2024 Q3	$4.26M	Buy	50,821 +2,468	+5%	+$188K	0.35%	68
2024 Q2	$3.32M	Buy	48,353 +1,522	+3%	+$102K	0.31%	74
2024 Q1	$3.43M	Buy	46,831 +38,662	+473%	+$2.97M	0.35%	71
2023 Q4	$662K	Buy	+8,169	New	+$636K	0.81%	24

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Plato Investment Management's GILD Position: Q1 2026 in Review

Plato Investment Management increased its Gilead Sciences (GILD) stake by 5% in Q1 2026, buying an estimated $340K and bringing the position to 51,281 shares worth $7.15M. The position accounts for 0.48% of the portfolio, ranked #42.

Plato Investment Management first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Plato Investment Management held 51,281 shares of Gilead Sciences worth $7.15M as of Q1 2026.
Plato Investment Management bought 2,426 Gilead Sciences shares in Q1 2026, an estimated $340K.
Gilead Sciences made up 0.48% of Plato Investment Management's portfolio in Q1 2026, its #42 holding.
Plato Investment Management first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Plato Investment Management's 13F filing for Q1 2026, filed 5 May 2026.